DAIICHI-SANKYO
LIVE

Serial Number

79137242

Owner

DAIICHI SANKYO COMPANY, LIMITED

Attorney

Bassam N. Ibrahim

Filing Date

Dec 7, 2012

Add to watchlist:

No watchlists yet
View on USPTO

DAIICHI-SANKYO Trademark

Serial Number: 79137242 • Registration: 4733605

DAIICHI-SANKYO is a trademark filed by DAIICHI SANKYO COMPANY, LIMITED on December 7, 2012. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

DAIICHI SANKYO COMPANY, LIMITED (329 trademarks)

3-5-1, NIHONBASHI HONCHO, CHUO-KU
TOKYO 103-8426 , JP

Entity Type: 03

Trademark Details

Filing Date

December 7, 2012

Registration Date

May 12, 2015

Published for Opposition

February 24, 2015

Goods & Services

Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, atherosclerosis, diabetic nephropathy, stroke, heart attack, hypercholesterolemia, dyslipidemia, anemia, blood disorders, diabetes, thyroid function disease, cancer, oncological disease, metastasis, autoimmune disease, allergy, bacterial infection, viral infection, fungal infection, inflammation, musculoskeletal disorders, pain, osteoporosis, Alzheimer's disease, obesity, anorexia, urinary and kidney disease, respiratory disease, gastrointestinal disease; vaccines; diagnostic reagents and contrast media for medical use; [veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidium in chickens and dysentery in pigs; sanitary preparations for medical use and sanitary preparations for agricultural use, namely, herbicides, fungicides, insecticides, bactericides and rodenticides; oiled paper for medical purposes; facial masks for sanitary purposes, not for medical personnel, namely, masks used for germ, virus, and allergen prevention sold as part of a kit consisting primarily of sanitizing preparations for household use; drug delivery agents in the form of edible wafers for wrapping a dose of powdered medicine, namely, unit dose gelatin or starch based dissolvable thin film sold empty for pharmaceuticals; gauze for dressings; unit dose capsules sold empty for pharmaceuticals; eye patches for medical use; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical use; adhesive plasters for medical use; bandages for dressings; collodion for medical use; breast-nursing pads; dental impression material; dental cements; dental abrasives; dental mastics; lactose for pharmaceutical purposes; powdered milk for babies; dietetic beverages, namely, nutritionally fortified beverages, vitamin fortified beverages and mineral fortified beverages adapted for medical purposes; baby foods; edible plant fibers, namely, dietary fibers for use as non-nutritive additives for food products to aid digestion; ground flaxseed fibers used in dietary supplements]

[Medical clinics; hospitals; health care; medical assistance services; physical therapy; medical nursing services; pharmaceutical advice; plastic surgery; telemedicine services; pharmacists' services to make up prescriptions; veterinary assistance services;] providing healthcare advisory services and information in the fields of pharmaceutical preparations, pharmaceutical products, medicines, medical treatment, diseases and administration of medicines; [preparation] and [dispensing of medications; medical services;] providing information relating to healthcare

[Chemical food preservatives; chemical plasticizers for use as high polymer stabilizers for plastics and paints; synthetic chemical polymer stabilizers for use as light stabilizers for plastics and coatings; chemical additives for use in the manufacture of foods; chemical antioxidants for use in the manufacture of drinks, cakes, flavoring agents, dairy products and fish paste products; chemical germination controllers, namely, gibberellins for grapes, oranges and for domestic and agricultural use; diagnostic reagents for in vitro scientific use; diagnostic preparations for in vitro biological tests, namely, for urine and blood tests, for blood glucose tests, for clotting tests, all for scientific use; enzyme preparations for use in vitro scientific use; soil conditioners, namely, soil improving agents and plant growth regulators for agricultural use; tetrodotoxins for scientific research use; adhesives not for stationery or household purposes; plant growth regulating preparations; fertilizers; higher fatty acid for use as food additive for food manufacturing; chemical test paper; artificial sweeteners]

Technical research in the fields of pharmaceutical products, medicines and cosmetics; project studies, namely, research relating to pharmaceutical products, medicines and cosmetics; technical project studies, namely, research relating to pharmaceutical products, medicines and cosmetics; research on civil engineering; research and development for others in the fields of pharmaceutical products, medicines and cosmetics; quality testing in the fields of pharmaceutical products, medicines and cosmetics; quality evaluation of pharmaceutical products, medicines and cosmetics; chemical analysis in the fields of pharmaceutical products, medicines and cosmetics; chemistry services in the nature of chemistry consultation in the fields of pharmaceutical products, medicines and cosmetics; chemical research in the fields of pharmaceutical products, medicines and cosmetics; cosmetic research; bacteriological research relating to pharmaceutical preparations and medicine; biological research relating to pharmaceutical preparations and medicine; product research and development in the fields of medical and pharmaceutical preparations and medicines; research and development relating to manufacturing processes in the fields of medical and pharmaceutical preparations and medicines; research and development, namely, conducting clinical trials for others

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Mar 25, 2026 NA71
REGISTERED-SEC.71 ACCEPTED
Mar 25, 2026 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 8, 2026 APRE
TEAS SECTION 71 RECEIVED
Nov 3, 2025 ES71
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
May 12, 2024 REM4
PARTIAL INVALIDATION PROCESSED BY THE IB
May 22, 2023 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 6, 2023 INPS
INVALIDATION PROCESSED
Apr 6, 2023 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 14, 2023 INPR
INTERNATIONAL REGISTRATION RENEWED
Jan 6, 2023 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Jun 14, 2022 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Jun 14, 2022 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 23, 2022 APRE
TEAS SECTION 71 & 15 RECEIVED
Nov 11, 2021 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 12, 2020 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jul 26, 2019 NREP
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 18, 2016 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Mar 18, 2016 CRCV
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 18, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 3, 2015 FICS
FINAL DISPOSITION PROCESSED
Sep 3, 2015 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 12, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
May 12, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 24, 2015 NPUB
PUBLISHED FOR OPPOSITION
Feb 24, 2015 PUBO
NOTIFICATION PROCESSED BY IB
Feb 19, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 4, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 4, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 4, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 21, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 20, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 16, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 16, 2015 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 16, 2015 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Jan 2, 2015 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Jan 2, 2015 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Jan 2, 2015 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 8, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 8, 2014 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 1, 2014 ERFR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 22, 2014 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Oct 16, 2014 CRCV
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 3, 2014 GNFN
FINAL REFUSAL E-MAILED
Jun 3, 2014 GNFR
FINAL REFUSAL WRITTEN
Jun 3, 2014 CNFR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 15, 2014 CHAN
TEAS/EMAIL CORRESPONDENCE ENTERED
May 15, 2014 TEME
ASSIGNED TO LIE
May 5, 2014 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 18, 2014 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 18, 2014 TROA
REFUSAL PROCESSED BY IB
Nov 16, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 29, 2013 RFCS
REFUSAL PROCESSED BY MPU
Oct 29, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 29, 2013 RFCR
NON-FINAL ACTION WRITTEN
Oct 28, 2013 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 26, 2013 MAFR
ASSIGNED TO EXAMINER
Oct 22, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 22, 2013 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 22, 2013 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 18, 2013 REPR